Skip to main navigation Skip to search Skip to main content

Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome

  • Pietro Ravani
  • , Alessandro Ponticelli
  • , Chiara Siciliano
  • , Alessia Fornoni
  • , Alberto Magnasco
  • , Felice Sica
  • , Monica Bodria
  • , Gianluca Caridi
  • , Changli Wei
  • , Mirco Belingheri
  • , Luciana Ghio
  • , Sandra Merscher-Gomez
  • , Alberto Edefonti
  • , Andrea Pasini
  • , Giovanni Montini
  • , Corrado Murtas
  • , Xiangyu Wang
  • , Daniel Muruve
  • , Augusto Vaglio
  • , Davide Martorana
    • Antonello Pani, Francesco Scolari, Jochen Reiser, Gian M. Ghiggeri

Research output: Contribution to journal › Article › peer-review

117   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science